New Key Statistics Module, Z-Score and F-Score
NAS:KRTX Key Ratios
| Market Cap $ M | 12,599.27 |
| Enterprise Value $ M | 11,353.14 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 10.01 |
| Price/Sales | 17,359.47 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -11.72 |
| Beneish M-Score | -9.51 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -52.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -22.95 |
| EV-to-EBITDA | -23.03 |
| PEG | -- |
| Shares Outstanding M | 38.20 |
| Net Margin (%) | -66,311.93 |
| Operating Margin % | -75,653.98 |
| Pre-tax Margin (%) | -66,209.48 |
| Quick Ratio | 19.31 |
| Current Ratio | 19.31 |
| ROA % (ttm) | -31.55 |
| ROE % (ttm) | -32.80 |
| ROIC % (ttm) | -2,178.08 |
| Dividend Yield % | -- |
| Altman Z-Score | 91.22 |
KRTX Number of Guru Trades
KRTX Volume of Guru Trades
Gurus Latest Trades with NAS:KRTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KRTX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Karuna Therapeutics Inc Insider Transactions
No Available Data
News about NAS:KRTX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers